CD8A and Behcet disease: In order to improve CD8+ T‐cell immunity to EBV, individuals with BD could be treated by intravenously infusing EBV‐specific cytotoxic CD8+ T cells after expansion in vitro, as in the treatment of patients with MS.56, 57